Abstract
Previously, tamoxifen (TAM) has been shown to induce apoptosis through elevation of intracellular Ca2+ in HepG2 human hepatoblastoma cells. In this study we investigated the role of reactive oxygen species (ROS) in the TAM-induced apoptosis, and interrelationship between intracellular Ca2+ and ROS. TAM induced a slow and sustained increase in intracellular ROS level. An antioxidant, N-acetylcysteine significantly inhibited both ROS production and apoptosis induced by TAM, suggesting that ROS may play an essential role in the TAM-induced apoptosis. In a time frame ROS generation followed intracellular Ca2+ increase, and the extracellular and intracellular Ca2+ chelation with EGTA and BAPTA/AM, respectively, completely inhibited the TAM-induced ROS production, indicating that intracellular Ca2+ may mediate the ROS generation. Inhibitors of NAD(P)H oxidase, diphenylene iodonium, phenylarsine oxide and neopterine, significantly blocked the TAM-induced ROS generation and apoptosis, implying that this oxidase may act as a source enzyme for the production of ROS. These results suggest that non-phagocytic NAD(P)H oxidase may play a novel role as a mediator of the apoptosis associated with intracellular Ca2+ in HepG2 cells. Cell Death and Differentiation (2000) 7, 925–932
Similar content being viewed by others
Introduction
Tamoxifen (TAM) has been used to treat breast cancer,1 with the potential for application as a cancer-preventing agent.2 Although the antiestrogenic properties of TAM appear to be responsible for the anticancer activities of TAM in breast cancer,3 the exact mechanisms of the actions of TAM are not yet clearly understood.
Apoptosis is a highly organized cell death process characterized by early and prominent condensation of nuclear chromatin, loss of plasma membrane phospholipid asymmetry, activation of proteases and endonucleases, enzymatic cleavage of the DNA into oligonucleosomal fragments, and segmentation of the cells into membrane-bound apoptotic bodies.4 TAM has been shown to induce apoptotic cell death in many types of tumor cells regardless of existence of estrogen receptor (ER).5,6,7,8 Although the signal transduction mechanisms by which TAM induces apoptosis in ER-negative tumor cells are essentially unknown, it is found to be associated with activation of the transcription factor NF-κB,7 or increased c-myc expression.8 Recently, we have also reported that TAM induces apoptosis through the activation of intracellular Ca2+ signal in ER-negative HepG2 human hepatoblastoma cells.9
Accumulating evidence implies that intracellular Ca2+ is commonly involved in the mechanism of apoptosis.10 One of the targets for elevated intracellular Ca2+ is the activation of the Ca2+-dependent protein kinases and phosphatases11 which has been seen during apoptosis.12 Direct activation of the Ca2+-dependent proteinase may represent another target for intracellular Ca2+ action in apoptosis.13 Ca2+/Mg2+-dependent endonuclease whose activation results in DNA fragmentation, the most characteristic biochemical feature of apoptosis,14 and Ca2+-dependent transglutaminase which is highly activated in apoptotic cells,15 also appear to be a target for Ca2+ action.16,17 The in vitro antitumor actions of TAM have been explained by its ability to perturb intracellular Ca2+ homeostasis.9,18 In HepG2 cells we have found that TAM induced a sustained Ca2+ influx through activation of non-specific cation channels leading to apoptotic cell death.9
There are numerous reports showing that oxidants kill cells by inducing apoptosis.19,20,21 In addition, oxidative stress is proposed as a common mechanism by which various agents induce apoptosis.22 Recently, reactive oxygen species (ROS) have also been demonstrated to play an essential role in apoptosis induced by TAM in ER-negative human cancer cells.7,23
Intracellular Ca2+ appears to be essential for generation of ROS in many cell types, including mitogen-activated human lymphocytes24 and growth factor-stimulated human keratinocytes.25 Extracellular Ca2+ influx is necessary for ROS generation during respiratory burst in human neutrophils.26 ROS production stimulated by excitotoxin is dependent on intracellular Ca2+ in rat cerebellar granule cells.27
Based on these previous findings, we hypothesized that TAM induces apoptosis through ROS generation mediated by elevated intracellular Ca2+. To verify this hypothesis, in this study we investigated (i) the role of ROS in the TAM-induced apoptosis in ER-negative HepG2 human hepatoblastoma cells, (ii) the cause-and-effect relationship between intracellular Ca2+ and ROS acting as a mediator of apoptosis, and (iii) the potential sites of ROS generation induced by TAM in the HepG2 cells.
Results
Induction of apoptotic cell death by TAM
We have previously reported that TAM induced apoptotic cell death in time- and concentration-dependent manners in the HepG2 cells.9 In this study we confirmed the apoptotic activity of TAM in the cells. TAM induced DNA fragmentation in a concentration-dependent manner studied by agarose gel electrophoresis as depicted in Figure 1A. This effect of TAM was prominent at the concentration of 30 μM. TAM also induced loss of phospholipid asymmetry, resulting in appearance of phosphatidylserine on the outer layer of the plasma membrane detected by annexin-V binding, as depicted in Figure 1B. Furthermore, TAM induced apoptosis in a time-related manner tested by flow cytometry by determining hypodiploid DNA content stained with PI28 as shown in Figure 1C. Taken together, these results indicate that TAM induced apoptotic cell death in the HepG2 cells.
Role of ROS in the TAM-induced apoptosis
To determine the role of ROS in the TAM-induced apoptosis of HepG2 cells, we first examined whether TAM generates ROS assessed by 2′,7′-dichlorofluorescin diacetate (DCFH) fluorescence.29 As shown in Figure 2A, TAM (30 μM) induced a slow and sustained increase in intracellular ROS level, and this increase continued for at least 1 h, depicted in Figure 2B. The TAM-generated ROS was completely inhibited by an antioxidant, N-acetylcysteine (NAC) (50 mM) as illustrated in Figure 2B. To determine the role of ROS in the TAM-induced apoptosis, we investigated whether NAC could suppress the apoptosis induced by TAM. As shown in Figure 2C, NAC (50 mM) significantly lowered hypodiploid DNA content induced by TAM, indicating that ROS may be involved in the mechanism of the TAM-induced apoptosis in the HepG2 cells.
Role of intracellular Ca2+ on the ROS generation and apoptosis induced by TAM
Next, we investigated the possible interrelationship between intracellular Ca2+ and ROS in the apoptosis-inducing activity of TAM. Time-dependent changes in the levels of intracellular Ca2+ and ROS induced by TAM (30 μM) was compared with each other. Intracellular Ca2+ increase preceded the ROS generation as shown in Figure 3A. In addition, the TAM-induced ROS production was completely prevented by treatment with ethylene glycol-bis-(aminoethyl ether)N,N,N,N-tetraacetic acid (EGTA) (1 mM) and bis-(o-aminophenoxy)-ethane-N,N,N,N-tetraacetic acid/acetoxymethyl ester (BAPTA/AM) (1 μM), an extracellular and intracellular Ca2+ chelator, respectively, as illustrated in Figure 3B. These results imply that intracellular Ca2+ may act as an early signal for the production of ROS by TAM.
Role of NAD(P)H oxidase in the TAM-induced ROS generation and apoptosis
To clarify the sites of the TAM-induced ROS production, we investigated the effects of various drugs that inhibit the mitochondrial respiratory chain enzymes or non-mitochondrial ROS-generating enzymes, on the TAM-induced ROS generation and apoptosis. The results were summarized in Table 1. The effects of TAM (30 μM) on the ROS level and apoptosis were not significantly altered either by inhibition of mitochondrial electron transport with inhibitors of Complex I, succinate dehydrogenase or Complex III (10 μM rotenone, 5 mM malonate, rotenone+malonate, and 5 μM antimycin A, respectively) or by the mitochondrial uncoupler, carbonylcyanide-p-(trifluoromethoxy)phenylhydrazone (FCCP) (0.1 μM). These mitochondrial enzyme inhibitors did not have a significant influence on the basal level of ROS and apoptosis, except that antimycin A and FCCP significantly increased only the basal level of ROS. These results indicate that mitochondria may not be the site of ROS production induced by TAM.
Thus, we examined whether non-mitochondrial ROS-generating enzymes contribute to the TAM-induced ROS production. The effects on the ROS and apoptosis of inhibitors of enzymes which can potentially generate ROS, cyclooxygenase, cytochrome P-450, nitric oxide synthase, xanthine oxidase and ribonucleotide reductase (100 μM indomethacin, 500 μM metyrapone, 100 μM NG-monomethyl-L-arginine (NMMA), 100 μM allopurinol and 1.5 mM hydroxyurea, respectively) were tested. The results showed that all drugs tested did not significantly influence the TAM-induced ROS increase and apoptosis, implying that these enzymes may not be actively involved in the TAM effects.
In contrast, inhibitors of membrane-bound NAD(P)H oxidase, 5 μM diphenylene iodonium (DPI),30 10 μM phenylarsine oxide (PAO)31 and 100 μM D-(+)-neopterine (NEO),32 significantly suppressed both the ROS generation and apoptosis induced by TAM as shown in Figure 4A,B, respectively. As a matter of fact, the activity of NAD(P)H oxidase similar to that found in neutrophils, has been detected in the HepG2 cells.33 Thus, these results strongly suggest that non-phagocytic NAD(P)H oxidase may act as a major site of ROS generation induced by TAM in the HepG2 cells.
Discussion
Although anti-cancer actions of TAM have been originally known to be due to its ability to inhibit ER,34 TAM appears to be effective for many cancer cells in which ER is not expressed.1 Previously, we have reported that TAM induces apoptotic cell death in ER-negative HepG2 human hepatoma cells,9 which was confirmed in this study by DNA fragmentation assay through gel electrophoresis, measurement of hypodiploid DNA contents through flow cytometry and detection of cell-surface phosphatidylserine with annexin-V conjugates (Figure 1). However, the exact mechanism of this non-genomic action of TAM remains unclear.
The mechanism of the induction of apoptosis by TAM in ER-negative tumor cells is supposed to be related to non-genomic actions of TAM, for example, inhibition of calmodulin kinase35 or protein kinase C.36 In the HepG2 cells the TAM-induced apoptosis seems to be mediated by intracellular Ca2+ whose involvement in apoptosis has been extensively studied in various cell types.9,37 The results of this study suggest that ROS may also be involved in the TAM-induced apoptosis, since TAM generated ROS (Figure 2A,B), and an antioxidant NAC significantly inhibited apoptosis induced by TAM (Figure 2C).
Since interplay between intracellular Ca2+ and ROS has been shown in many cellular systems,38,39 we hypothesized that there is a cause-and-effect relationship between intracellular Ca2+ and ROS as a mediator of the TAM-induced apoptosis in the HepG2 cells. The results of the present study strongly suggest that ROS may be a downstream signal of elevated intracellular Ca2+. The TAM-induced generation of ROS was preceded by elevation of intracellular Ca2+ in a time frame (Figure 3A), and completely inhibited by reducing extracellular Ca2+ concentration with a nominal Ca2+-free medium containing EGTA and chelating intracellular Ca2+ with BAPTA/AM (Figure 3B).
The major biological process leading to oxygen-derived ROS generation is electron transport associated with mitochondrial membranes.40 In mitochondria complex III can generate ROS, especially in the presence of compounds that prolong the lifetime of ubisemiquinone.14 Therefore, if the site of the TAM-induced ROS increase is mitochondria, mitochondrial inhibitors that suppress the formation of ubisemiquinone at complex III should abolish the increase in ROS seen by treating with TAM. However, rotenone and malonate (inhibitors of NADH dehydrogenase and succinate dehydrogenase, respectively) treated alone or together, did not have a significant influence on the TAM-induced ROS generation and apoptosis (Table 1). As expected, antimycin A, a complex III inhibitor augmented the basal production of ROS probably through prolonging the lifetime of ubisemiquinone,41 but it did not enhance the ROS production and apoptosis induced by TAM (Table 1). In addition, FCCP, a mitochondrial uncoupler also increased the basal ROS level, which is consistent with the results of other studies,42 but it had no effect on the TAM-induced ROS production and apoptosis. Taken together, these results strongly suggest that mitochondria may not be the site of ROS generation induced by TAM.
ROS can also be generated by non-mitochondrial sites. ROS appear to be produced by the microsomal enzyme, cytochrome P-450, and numerous catalytic cytosolic enzymes, including cyclooxygenase, nitric oxide synthase, xanthine oxidase and ribonucleotide reductase.43 The specific inhibitors of these enzymes (500 μM metyrapone, 100 μM indomethacin, 100 μM NMMA, 100 μM allopurinol and 1.5 mM hydroxyurea, respectively) were not effective for preventing the TAM-induced ROS production and apoptosis (Table 1), demonstrating that these non-mitochondrial enzymes may not be involved in the ROS generation by TAM in the HepG2 cells.
The membrane-bound NADPH oxidase is known to produce ROS during the respiratory burst in neutrophils.44 The enzyme has also been involved in the ROS-mediated apoptosis in human leukemia cells.45 The activation of this enzyme proceeds through a multistep assembly at the plasma membrane of several components including the two subunits of cytochrome b558 (p22phox and gp91phox), the small GTP-binding proteins (Rac and Rap1A), and the cytosolic factors (p40phox, p47phox and p67phox).44,46 Recently, these components have also been detected and functionally active in non-phagocytic cells, including endothelial cells,47 vascular smooth muscle cells,48 neuroepithelial bodies of the lung49 and type I cells of the carotid body.50 Interestingly, this enzyme acts as a main system to produce ROS during oxidative stress condition in vascular cells.51,52
HepG2 cells used in this study have been shown to express these components found in the NADPH oxidase complex of neutrophils.53,54 This enzyme system appears to be a major source of ROS produced particularly in association with hypoxia-induced erythropoietin expression in the HepG2 cells.53 Therefore, we examined whether the membrane-bound NAD(P)H oxidase contributes to the TAM-induced ROS generation. The significant suppression of the TAM-induced production of ROS (Figure 4A) and apoptosis (Figure 4B) by various inhibitors of the enzyme (DPI, PAO and NEO) suggest that the membrane-bound NAD(P)H oxidase may be actively involved in the production of ROS induced by TAM.
Currently, we do not know the exact mechanism by which TAM activates the NAD(P)H oxidase in the HepG2 cells. However, antagonistic effects of Ca2+ inhibitors on the TAM-induced ROS generation (Figure 3B) suggest involvement of intracellular Ca2+ signal. Recently, Cool et al.54 have demonstrated that in HepG2 cells Rac1, a small GTP binding protein is involved in the regulation of ROS production by the non-phagocytic NAD(P)H oxidase complex. In addition, Ca2+/CaM-dependent protein kinase-II has been demonstrated to phosphorylate and regulate Tiam1,55 a Rac1-specific exchange factor.56 Thus, although speculated, there is a possibility that elevated Ca2+ by TAM activates Ca2+/CaM-dependent protein kinase-II, which in turn, activates Tiam1, leading to activation of Rac1. Moreover, Orie et al.57 have recently found that Ca2+/CaM-dependent protein kinase-II is a common signaling component in the generation of ROS in human lymphocytes. The involvement of Ca2+/CaM-dependent protein kinase-II in the TAM-induced activation of NAD(P)H oxidase in the HepG2 cells remains to be elucidated in the future.
In conclusion, TAM induced apoptosis through generation of ROS in HepG2 human hepatoblastoma cells. TAM may activate NAD(P)H oxidase via increasing intracellular Ca2+ concentration, which results in the production of ROS and apoptosis. However, since the concentration of tamoxifen used in this study (30 μM) may not be obtainable in vivo, one should consider it cautiously when these results may be interpreted as the mechanism of the actions of tamoxifen in vivo. Nevertheless, these results suggest that NAD(P)H oxidase may have a novel role in apoptotic cell death induced by TAM, an activator of intracellular Ca2+ signal in the HepG2 cells.
Materials and Methods
Materials
The powders Eagle's minimum essential medium (MEM) and Earle's basal salt solution, trypsin solution (EBSS), EGTA, TAM, NAC, rotenone, malonate, antimycin A, indomethacin, metyrapone, allopurinol, NMMA, FCCP, hydroxyurea, DPI, PAO, NEO, sodium pyruvate, probenecid, PI, ribonuclease A and all salt powders were obtained from Sigma Chemical Co. (St. Louis, MO, USA). 1-(2,5-Carboxyoxazol-2-yl-6-aminobenzfuran-5-oxyl)-2-(2′-amino-methylphenoxy)- ethane-N,N,N,N-tetraacetoxylmethyl ester (Fura-2/AM), BAPTA/AM and DCFH-DA were from Molecular Probes, Inc. (Eugene, OR, USA). Fetal bovine serum (FBS) and antibiotics (penicillin and streptomycin mixture) were purchased from GIBCO (Grand Island, NY, USA). Fura-2/AM, BAPTA/AM and DCFH-DA were prepared as stock solutions in dimethyl sulfoxide (DMSO), then diluted with aqueous medium to the final desired concentrations. The stock solutions of drugs were sterilized by filtration through 0.2 μm disc filters (Gelman Sciences: Ann Arbor, MI, USA).
Cell line and cell culture
HepG2 human hepatoblastoma cell line was purchased from American Type Culture Collection (Rockville, MA, USA). HepG2 cells were grown at 37°C in a humidified incubator under 5% CO2/95% air in a MEM supplemented with 10% FBS, 200 IU/ml penicillin, 200 μg/ml of streptomycin and 1 mM sodium pyruvate. Culture medium was replaced every other day. After attaining confluence the cells were subcultured following trypsinization.
DNA isolation and electrophoresis
DNA isolation was done according to Hockenbery et al.58 HepG2 cells were collected by centrifugation (200×g, 10 min), washed twice in phosphate buffered saline (PBS) (pH 7.4) and resuspended at a density of 4×106 cells/400 μl in hypotonic lysing buffer (5 mM Tris, 20 mM EDTA, pH 7.4) containing 0.5% Triton X-100 for 30 min at 4°C. The lysates were centrifuged at 13 000×g for 15 min at 4°C. Fragmented DNA was extracted from the supernatant with phenol-chloroform-isoamylalcohol, precipitated by addition of 2 volume of absolute ethanol and 0.1 volume of 3 mM sodium acetate, and treated with RNAse A (500 U/ml) at 37°C for 3 h. The pattern of DNA fragmentation was visualized by electrophoresis in 1.8% agarose gel containing ethidium bromide and photographed under UV light.
Intracellular ROS measurement
Relative changes in intracellular ROS in the HepG2 cells were monitored using a fluorescent probe, DCFH-DA.29 DCFH-DA diffuses through the cell membrane readily and is hydrolyzed by intracellular esterases to nonfluorescent DCFH, which is then rapidly oxidized to highly fluorescent DCF in the presence of ROS. The DCF fluorescence intensity is proportional to the amount of ROS formed intracelularly.59 Cells were washed twice and resuspended at a concentration of 4×105 cells/ml in Hank's solution. For loading DCFH-DA into the cells, cells were incubated with the dye for 2 h at a final concentration of 5 μM at 37°C. Fluorescence (excitation wavelength set at 485 nm and the emission wavelength at 530 nm) was monitored in a well-stirred cuvette.
Intracellular Ca2+ measurement
Aliquots of the HepG2 cells were washed in EBSS. Then, 5 μM Fura-2 was added, and the cells were incubated for 30 min at 37°C. Unloaded Fura-2 was removed by centrifugation at 150×g for 3 min. Cells were resuspended at a density of 2×106 cells/ml in Krebs-Ringer buffer containing 125 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5 mM NaHCO3, 25 mM HEPES, 6 mM glucose and 2.5 mM probenecid (pH 7.4). Fura-2-loaded cells were maintained at 25°C for 90 min before fluorescence measurement. For each experiment, 0.5 ml aliquot of Fura-2-loaded cells was equilibrated to 37°C in a stirred quartz cuvette. Fluorescence emission (510 nm) was monitored with the excitation wavelength cycling between 340 and 380 nm using a Hitachi F4500 fluorescence spectrophotometer. At the end of an experiment, fluorescence maximum and minimum values at each excitation wavelength were obtained by lysis of cells with 20 μg/ml digitonin (maximum) and then adding 10 mM EGTA (minimum). With the maximum and minimum values, the 340 : 380 nm fluorescence ratios were converted into free Ca2+ concentrations using a software, F-4500 Intracellular Cation Measurement System, provided by Hitachi.
Flow cytometric analysis of apoptosis
For flow cytometry analysis, HepG2 cells were collected and washed twice with PBS buffer (pH 7.4). After fixing in 80% ethanol for 30 min, cells were washed twice, and resuspended in PBS buffer (pH 7.4) containing 0.1% Triton X-100, 5 μg/ml PI and 50 μg/ml ribonuclease A for DNA staining. Cells were then analyzed by a FACScan (BIO-RAD, Hercules, CA, USA). At least 20 000 events were evaluated. All histograms were analyzed using WinBryte software (BIO-RAD, Hercules, CA, USA) to determine percentage of nuclei with hypodiploid content indicative of apoptosis.28
The normal lipid organization of the plasma membrane is altered soon after apoptosis is initiated. Thus, annexin-V binding was also employed as an indicator of apoptosis60 to demonstrate the loss of phospholipid asymmetry and the presence of phosphatidylserine on the outer layer of the plasma membrane. It was analyzed using a commercial kit (Boehringer Mannheim Biochemicals, Mannheim, Germany). Cells were washed in cold PBS, and resuspended in binding buffer. A portion of cell suspension (500 μl) was exposed to Annexin-V-FLUOS. The cells were gently vortexed, incubated at room temperature for 20 min in the dark, and then analyzed by FACScan within 1 h of staining.
Data analysis
All experiments were performed four times. Data were expressed as mean±standard error of the mean (S.E.M.) and were analyzed using one way analysis of variance (ANOVA) and Student-Newman-Keul's test for individual comparisons. P values less than 0.05 are considered statistically significant.
Abbreviations
- BAPTA/AM:
-
bis-(o-aminophenoxy)-ethane-N,N,N,N-tetraacetic acid/acetoxymethyl ester
- EGTA:
-
ethylene glycol-bis-(aminoethyl ether)N,N,N,N-tetraacetic acid
- ER:
-
estrogen receptor
- DCFH-DA:
-
2′,7′-dichlorofluorescin diacetate
- DPI:
-
diphenylene iodonium
- FCCP:
-
carbonylcyanide-p-(trifluoromethoxy)phenylhydrazone
- Fura-2/AM:
-
1-(2,5-Carboxyoxazol-2-yl-6-aminobenzfuran-5-oxyl)-2-(2′-amino-methylphenoxy)-ethane -N,N,N,N-tetraacetoxylmethyl ester
- NAC:
-
N-acetylcysteine
- NEO:
-
D-(+)-neopterine
- NMMA:
-
NG-monomethyl-L-arginine
- PAO:
-
phenylarsine oxide
- PI:
-
propidium iodide
- ROS:
-
reactive oxygen species
- TAM:
-
tamoxifen
References
Jordan VC . 1990 Long-term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Res. Treat. 15: 125–136
Nayfield SG, Karp JE, Ford LG, Dorr FA and Kramer BS . 1991 Potential role of tamoxifen in prevention of breast cancer. J. Natl. Cancer Inst. 83: 1450–1459
Kon OL . 1989 Estrogens, antiestrogens and cell proliferation. Bioessays. 10: 210–214
Kidd VJ . 1998 Proteolytic activities that mediate apoptosis. Annu. Rev. Physiol. 60: 533–573
Keen JC, Dixon JM, Miller EP, Cameron DA, Chetty U, Hanby A, Bellamy C and Miller WR . 1997 The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer. Breast Cancer Res. Treat. 44: 123–133
Ellis PA, Saccani-Jotti G, Clarke R, Johnston SR, Anderson E, Howell A, A'Hern R, Salter J, Detre S, Nicholson R, Robertson J, Smith IE and Dowsett M . 1997 Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int. J. Cancer 72: 608–613
Ferlini C, Scambia G, Marone M, Distefano M, Gaggini C, Ferrandina G, Fattorossi A, Isola G, Benedetti Panici P and Mancuso S . 1999 Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br. J. Cancer 79: 257–263
Kang Y, Cortina R and Perry RR . 1996 Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J. Natl. Cancer Inst. 88: 279–284
Kim JA, Kang YS, Lee SH, Lee EH and Lee YS . 1999 Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. Cancer Lett. 147: 115–123
McConkey DJ and Orrenius S . 1996 The role of calcium in the regulation of apoptosis. J. Leukoc. Biol. 59: 775–783
Bonnefoy-Berard N, Genestier L, Flacher M and Revillard JP . 1994 The phosphoprotein phosphatase calcineurin controls calcium-dependent apoptosis in B cell lines. Eur. J. Immunol. 24: 325–329
Shibasaki F, Kondo E, Akagi E and McKeon F . 1997 Suppression of signaling through NF-AT by interactions between calcineurin and BCL-2. Nature 386: 728–731
Squier MKT and Cohen JJ . 1997 Calpain, an upstream regulator of thymocyte apoptosis. J. Immunol. 158: 3690–3697
Wyllie AH, Morris RG, Smith AL and Dunlop D . 1984 Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142: 67
Fesus L, Thomazy V and Falus A . 1987 Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224: 104–108
Cohen JJ and Duke RC . 1984 Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132: 38–42
Melino G, Annicchiarico-Petruzzeli M, Piredda L, Candi E, Gentile V, Davies PJ and Piacentini M . 1994 Tissue transglutaminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell. Biol. 14: 6584–6596
Jain PT and Trump BF . 1997 Tamoxifen induces deregulation of [Ca2+] in human breast cancer cells. Anticancer Res. 17: 1167–1174
Gardner AM, Xu FH, Fady C, Jacoby FJ, Duffey DC, Tu Y and Lichtenstein A . 1997 Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic.Biol. Med. 22: 73–83
Jayanthi S, Ordonez S, McCoy MT and Cadet JL . 1999 Dual mechanism of Fas-induced cell death in neuroglioma cells: a role for reactive oxygen species. Brain Res. Mol. Brain Res. 72: 158–165
Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J and Marrack PC . 1999 Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735–744
Kamata H and Hirata H . 1999 Redox regulation of cellular signalling. Cell. Signal 11: 1–14
Hayon T, Dvilansky A, Oriev L and Nathan I . 1999 Non-steroidal antiestrogens induce apoptosis in HL60 and MOLT3 leukemic cells; involvement of reactive oxygen radicals and protein kinase C. Anticancer Res. 19: 2089–2093
Orie NN, Zidek W and Tepel M . 1999 Chemoattractant- and mitogen-induced generation of reactive oxygen species in human lymphocytes: the role of calcium. Exp. Physiol. 84: 515–520
Goldman R, Moshonov S and Zor U . 1998 Generation of reactive oxygen species in a human keratinocyte cell line: role of calcium. Arch. Biochem. Biophys. 350: 10–18
Khalfi F, Gressier B, Brunet C, Dine T, Luyckx M, Cazin M and Cazin JC . 1996 Involvement of the extracellular calcium in the release of elastase and the human neutrophils oxidative burst. Cell. Mol. Biol. 42: 1211–1218
Boldyrev AA, Carpenter DO, Huentelman MJ, Peters CM and Johnson P . 1999 Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells. Biochem. Biophys. Res. Commun. 256: 320–324
Bombeli T, Karsan A, Tait JF and Harlan JM . 1997 Apoptotic vascular endothelial cells become procoagulant. Blood 89: 2429–2442
LaBel CP, Ischiopoulos H and Bondy SC . 1992 Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5: 227–231
O'Donnell BV, Tew DG, Jones OT and England PJ . 1993 Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290: 41–49
Le Cabec V and Maridonneau-Parini I . 1995 Complete and reversible, inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane translocation of the enzyme subunits. J. Biol. Chem. 270: 2067–2073
Kojima S, Nomura T, Icho T, Kajiwara Y, Kitabatake K and Kubota K . 1993 Inhibitory effect of neopterin on NADPH-dependent superoxide-generating oxidase of rat peritoneal macrophages. FEBS Lett. 329: 125–128
Ehleben W, Porwol T, Fandrey J, Kummer W and Acker H . 1997 Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells. Kidney Int. 51: 483–491
MacGregor JI and Jordan VC . 1998 Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50: 151–196
Rowlands MG, Parr IB, McCague R, Jarman M and Goddard PM . 1990 Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity. Biochem. Pharmacol. 40: 283–289
Cheng AL, Chuang SE, Fine RL, Yeh KH, Liao CM, Lay JD and Chen DS . 1998 Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem. Pharmacol. 55: 523–531
Distelhorst CW and Dubyak G . 1998 Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings. Blood 91: 731–734
Supinski G, Nethery D, Stofan D and DiMarco A . 1999 Extracellular calcium modulates generation of reactive oxygen species by the contracting diaphragm. J. Appl. Physiol. 87: 2177–2185
Bae GU, Seo DW, Kwon HK, Lee HY, Hong S, Lee ZW, Ha KS, Lee HW and Han JW . 1999 Hydrogen peroxide activates p70(S6k) signaling pathway. J. Biol. Chem. 274: 32596–32602
Halliwell B . 1989 Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br. J. Exp. Pathol. 70: 737–757
Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N and Fernandez-Checa JC . 1995 Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol. 48: 825–834
Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP and Choi DW . 1995 Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15: 6377–6388
Yu BP . 1994 Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74: 139–162
Babior BM . 1995 The respiratory burst oxidase. Curr. Opin. Hematol. 2: 55–60
Hiraoka W, Vazquez N, Nieves-Neira W, Chanock SJ and Pommier Y . 1998 Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. J. Clin. Invest. 102: 1961–1968
Babior BM . 1999 NADPH oxidase: an update. Blood 93: 1464–1476
Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ and Jones OT . 1996 Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271: H1626–H1634
Marshall C, Mamary AJ, Verhoeven AJ and Marshall BE . 1996 Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 15: 633–644
Youngson C, Nurse C, Yeger H, Curnutte JT, Vollmer C, Wong V and Cutz E . 1997 Immunocytochemical localization on O2-sensing protein (NADPH oxidase) in chemoreceptor cells. Microsc. Res. Tech. 37: 101–106
Kummer W and Acker H . 1995 Immunohistochemical demonstration of four subunits of neutrophil NAD(P)H oxidase in type I cells of carotid body. J. Appl. Physiol. 78: 1904–1909
Kashiwagi A, Shinozaki K, Nishio Y, Maegawa H, Maeno Y, Kanazawa A, Kojima H, Haneda M, Hidaka H, Yasuda H and Kikkawa R . 1999 Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am. J. Physiol. 277: E976–E983
Brandes RP, Koddenberg G, Gwinner W, Kim DY, Kruse HJ, Busse R and Mugge A . 1999 Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension 33: 1243–1249
Ehleben W, Porwol T, Fandrey J, Kummer W and Acker H . 1997 Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells. Kidney Int. 51: 483–491
Cool RH, Merten E, Theiss C and Acker H . 1998 Rac1, and not Rac2, is involved in the regulation of the intracellular hydrogen peroxide level in HepG2 cells. Biochem. J. 332: 5–8
Fleming IN, Elliott CM, Buchanan FG, Downes CP and Exton JH . 1999 Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation. J. Biol. Chem. 274: 12753–12758
Collard JG, Habets GG, Michiels F, Stam J, van der Kammen RA and van Leeuwen F . 1996 Role of Tiam1 in Rac-mediated signal transduction pathways. Curr. Top. Microbiol. Immunol. 213: 253–265
Orie NN, Zidek W and Tepel M . 1999 Tyrosine and calcium/calmodulin kinases are common signaling components in the generation of reactive oxygen species in human lymphocytes. Life Sci. 65: 2135–2142
Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ . 1990 Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336
Shen HM, Shi CY and Ong CN . 1996 Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic. Biol. Med. 21: 139–146
Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C . 1995 A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184: 39–51
Acknowledgements
This work was supported by the Yeungnam University Research Grant in 2000 to J-A Kim.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by A Finazzi-Agio
Rights and permissions
About this article
Cite this article
Lee, Y., Kang, Y., Lee, S. et al. Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells. Cell Death Differ 7, 925–932 (2000). https://doi.org/10.1038/sj.cdd.4400717
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400717
Keywords
This article is cited by
-
Potentiating the anti-cancer profile of tamoxifen-loaded graphene using deep eutectic solvents as functionalizing agents
Applied Nanoscience (2020)
-
Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
Scientific Reports (2016)
-
Tamoxifen reduces fat mass by boosting reactive oxygen species
Cell Death & Disease (2015)
-
Comparison of cytotoxicity and genotoxicity of 4-hydroxytamoxifen in combination with Tualang honey in MCF-7 and MCF-10A cells
BMC Complementary and Alternative Medicine (2014)
-
SEURAT-1 liver gold reference compounds: a mechanism-based review
Archives of Toxicology (2014)